S3 E2 Tracy Tranchitella, ND – Hormone Replacement Therapy and Removal of Black Box Warning
About this episode
The episode discusses the implications of the FDA's black box warning on hormone replacement therapy and its impact on women's health.
For decades, the Food and Drug Administration (FDA) had maintained a black box warning for hormone replacement therapy regarding estrogen. This often-prevented women from receiving appropriate estrogen hormone replacement therapy (HRT) either because of a history breast cancer or other health concern. This long-standing policy dated back decades to the Women’s Health Initiative study which failed to account for various individual factors such as type of estrogen, dose, and individual sensitiv...
People in this episode
Host: Dr. Kurt Woeller
Guest: Tracy Tranchitella
Topics covered
- Hormone Replacement Therapy
- Black Box Warning
- Estrogen
- Women's Health
- FDA Policy
Keywords
- hormone replacement therapy
- black box warning
- estrogen
- FDA
- women's health
- breast cancer
- individual factors
Mentioned in this episode
Organizations: Food and Drug Administration, Women’s Health Initiative
More episodes of Functional Medicine Doc Talk
- S3 E3 Beth Lambert – Documenting Hope of Healing Solutions for Childhood Neurodevelopmental Disorders
- S3 E1 Jon Kaiser, MD Long-Covid, Long-Vax, ME/CFS and Recovery from Chronic Illness
- S2 E20 Lori Knowles-Jimenez – Getting Children to Take Supplements
- S2 E19 Manisha Diaz, PhD - Understanding Laboratory Technology, Compliance, and Regulations (Part 2)
- S2 E18 Nicole Johnson, MBA, MT, (ASCP) - Understanding Laboratory Technology, Compliance, and Regulations (Part 1)
- S2 E17 Lindsay Goddard, MS, RD, LDN- Pesticides, Other Chemicals, and Organic vs Non-Organic Food
Explore listener stats, chart rankings, contacts and more on the Functional Medicine Doc Talk podcast page.